The Campaign
Archimedes Pharma required PR support for its drug Pro-Banthine – an oral treatment for hyperhidrosis (excessive sweating). Although the drug had been available for many years, it was not widely known amongst GPs, dermatologists and patients.
Our PR strategy focused on re-launching the drug to the target audience, focusing on its key benefits of being effective and low-cost for the NHS.
Activity included:
- Media re-launch to health journalists
- Case study placement with national and regional media
- Pro-Banthine treatment submission to NHS Choices and Patient UK
- Briefing to media doctors
The Results
- Increased awareness and usage of the drug Pro-Banthine amongst practitioners and patients
- Widespread coverage in national and regional health and consumer media
- Inclusion of Pro-Banthine as a treatment option in key patient websites NHS Choices and Patient UK
What the client said...
“Our mature product became part of the treatment pathway for hyperhidrosis due to changes in the funding of the NHS. However, we needed to raise awareness with healthcare practitioners and Justine was able to secure significant PR coverage for us through national press and a number of relevant magazines. This raised awareness both of the condition and also of a valuable treatment option. This proved an important aspect of our marketing strategy and I would certainly endorse a PR campaign with Justine Rawlins PR.”
